📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Algeta

1.1 - Company Overview

Algeta Logo

Algeta

Headquarter: Norway
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of targeted oncology therapies based on an alpha-pharmaceutical platform, including radium-223 dichloride, which completed Phase III clinical trial to treat castration-resistant prostate cancer with bone metastases.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Algeta

Halozyme Logo

Halozyme

HQ: United States Website
  • Description: Provider of extracellular matrix-targeting products and drug delivery technologies, including ENHANZE to enable subcutaneous delivery and reduce administration time vs hours-long IV infusions; HYLENEX recombinant hyaluronidase to aid dispersion and absorption of injected drugs/fluids; XYOSTED testosterone enanthate for replacement therapy; and auto-injector platforms for subcutaneous/intramuscular use, with a partner pipeline in five approved therapeutics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Halozyme company profile →
Medigene Logo

Medigene

HQ: Germany Website
  • Description: Provider of biotechnology solutions for cancer treatment, offering an end-to-end platform for developing TCR-guided therapies—including TCR-T, TCR-T cell engagers, and TCR-natural killer cell therapies—focused on specificity, sensitivity, and safety. Pipeline includes MDG1015 (NY-ESO-1/LAGE-1a, PD1-41BB) and MDG2011 (KRAS G12V, PD1-41BB) for solid tumors, plus 3S TCR technology.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Medigene company profile →
GT MedTech Logo

GT MedTech

HQ: United States Website
  • Description: Provider of surgically targeted radiation therapy for operable brain tumors via GammaTile Therapy, delivering immediate, dose-intense treatment post-resection to extend local recurrence-free survival; conducts clinical trials evaluating GammaTile for newly diagnosed metastatic brain tumors and recurrent glioblastoma; and offers a digital Brain Resection Cavity Estimation Tool to aid tumor bed calculations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GT MedTech company profile →
Atrin Pharmaceuticals Logo

Atrin Pharmaceuticals

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery and development for innovative cancer treatments. The privately held company, based in Doylestown, PA, is engaged in the discovery and development of treatments for cancer, with its most advanced program focused on a new class of highly specific compounds.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atrin Pharmaceuticals company profile →
Galil Medical Logo

Galil Medical

HQ: United States Website
  • Description: Provider of minimally invasive cryotherapy technology and systems for various clinical applications, using compressed Argon gas to freeze and ablate diseased tissue in procedures referred to as cryotherapy, cryoablation, or cryosurgery.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Galil Medical company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Algeta

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Algeta

2.2 - Growth funds investing in similar companies to Algeta

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Algeta

4.2 - Public trading comparable groups for Algeta

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Algeta

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Algeta

What does Algeta do?

Algeta is a provider of targeted oncology therapies based on an alpha-pharmaceutical platform, including radium-223 dichloride, which completed Phase III clinical trial to treat castration-resistant prostate cancer with bone metastases.

Who are Algeta's competitors?

Algeta's competitors and similar companies include Halozyme, Medigene, GT MedTech, Atrin Pharmaceuticals, and Galil Medical.

Where is Algeta headquartered?

Algeta is headquartered in Norway.

How many employees does Algeta have?

Algeta has 1,000 employees 🔒.

When was Algeta founded?

Algeta was founded in 2010 🔒.

What sector and industry vertical is Algeta in?

Algeta is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Algeta

Who are the top strategic acquirers in Algeta's sector and industry

Top strategic M&A buyers and acquirers in Algeta's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Algeta?

Top strategic M&A buyers groups and sectors for Algeta include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Algeta's sector and industry vertical

Which are the top PE firms investing in Algeta's sector and industry vertical?

Top PE firms investing in Algeta's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Algeta's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Algeta's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Algeta's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Algeta include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Algeta's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Algeta?

The key public trading comparables and valuation benchmarks for Algeta include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Algeta for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Algeta with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Algeta's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Algeta with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Algeta's' sector and industry vertical?

Access recent funding rounds and capital raises in Algeta's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Algeta